Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
The Lipid-Rich Plaque Study
The Lipid-Rich Plaque (LRP) Study
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
HEART Pathway Implementation
The HEART Pathway: Bridging the Gap Between Operations, Research, and Education
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
HEART Pathway Implementation
The HEART Pathway: Bridging the Gap Between Operations, Research, and Education
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Omega 3 for Treatment of Depression in Patients With Heart Failure
Omega 3 for Comorbid Depression and Heart Failure Treatment
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
Status: Enrolling
Updated:  12/31/1969
Hennepin County Medical Center
mi
from
Minneapolis, MN
Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
Status: Enrolling
Updated: 12/31/1969
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System
A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA 2 Access System Compared to Manual Compression
Status: Enrolling
Updated:  12/31/1969
Borgess Medical Center
mi
from
Kalamazoo, MI
ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System
A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA 2 Access System Compared to Manual Compression
Status: Enrolling
Updated: 12/31/1969
Borgess Medical Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans
The Effect of Daily Dietary Supplementation With Cranberry Extract on Modulation of Cardiovascular Risk Factors in Obese, Insulin Resistant Human Subjects
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans
The Effect of Daily Dietary Supplementation With Cranberry Extract on Modulation of Cardiovascular Risk Factors in Obese, Insulin Resistant Human Subjects
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Role of Fat Emboli in the Trauma Inflammatory Response
The Role of Fat Emboli in the Trauma Inflammatory Response
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
The Role of Fat Emboli in the Trauma Inflammatory Response
The Role of Fat Emboli in the Trauma Inflammatory Response
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
Click here to add this to my saved trials
Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest
Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest
Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-iliac Aneurysms
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-iliac Aneurysms
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Center
mi
from
Grand Blanc, MI
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
The Institute of Ophthalmology and Visual Science (IOVS)
mi
from
Newark, NJ
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
The Institute of Ophthalmology and Visual Science (IOVS)
mi
from
Newark, NJ
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
MaculaCare
mi
from
New York, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Casey Eye Institute
mi
from
Portland, OR
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials